NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 908 filers reported holding NOVARTIS A G in Q1 2017. The put-call ratio across all filers is 2.34 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $238,000 | -12.8% | 2,941 | -9.7% | 0.01% | -11.1% |
| Q4 2017 | $273,000 | -9.3% | 3,256 | -7.1% | 0.01% | -18.2% |
| Q3 2017 | $301,000 | +2.7% | 3,506 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $293,000 | +12.7% | 3,506 | 0.0% | 0.01% | +10.0% |
| Q1 2017 | $260,000 | +1.6% | 3,506 | -0.3% | 0.01% | 0.0% |
| Q4 2016 | $256,000 | -15.5% | 3,516 | -8.5% | 0.01% | -9.1% |
| Q3 2016 | $303,000 | -4.4% | 3,841 | 0.0% | 0.01% | -8.3% |
| Q2 2016 | $317,000 | +18.7% | 3,841 | +4.3% | 0.01% | +33.3% |
| Q1 2016 | $267,000 | -16.8% | 3,681 | -1.5% | 0.01% | -10.0% |
| Q4 2015 | $321,000 | +14.6% | 3,736 | +22.7% | 0.01% | +25.0% |
| Q3 2015 | $280,000 | +1.8% | 3,046 | +8.9% | 0.01% | +14.3% |
| Q2 2015 | $275,000 | -0.4% | 2,796 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $276,000 | +16.9% | 2,796 | +9.8% | 0.01% | +16.7% |
| Q4 2014 | $236,000 | -1.7% | 2,546 | 0.0% | 0.01% | 0.0% |
| Q3 2014 | $240,000 | +4.3% | 2,546 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $230,000 | – | 2,546 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |